Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1475-2867
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Nanobody-armed T cells endow CAR-T cells with cytotoxicity against lymphoma cells ; volume:21 ; number:1 ; day:24 ; month:8 ; year:2021 ; pages:1-12 ; date:12.2021
Cancer cell international ; 21, Heft 1 (24.8.2021), 1-12, 12.2021
- Creator
-
Wang, Hongxia
Wang, Liyan
Li, Yanning
Li, Guangqi
Zhang, Xiaochun
Jiang, Dan
Zhang, Yanting
Liu, Liyuan
Chu, Yuankui
Xu, Guangxian
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12935-021-02151-z
- URN
-
urn:nbn:de:101:1-2021110920032330237838
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Hongxia
- Wang, Liyan
- Li, Yanning
- Li, Guangqi
- Zhang, Xiaochun
- Jiang, Dan
- Zhang, Yanting
- Liu, Liyuan
- Chu, Yuankui
- Xu, Guangxian
- SpringerLink (Online service)
Other Objects (12)
Nanobody-based CAR-T cells for cancer immunotherapy
Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
Engineering CAR-T cells
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Nanobody‐mediated complement activation to kill HIV ‐infected cells
T cell senescence and CAR-T cell exhaustion in hematological malignancies
CART cells are prone to Fas- and DR5-mediated cell death
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Progranulin Prevents Regulatory NK Cell Cytotoxicity Against Antiviral T Cells
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
Recent advances in CAR-T cell engineering
Nanobody-based CAR-T cells for cancer immunotherapy
Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
Engineering CAR-T cells
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Nanobody‐mediated complement activation to kill HIV ‐infected cells
T cell senescence and CAR-T cell exhaustion in hematological malignancies
CART cells are prone to Fas- and DR5-mediated cell death
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Progranulin Prevents Regulatory NK Cell Cytotoxicity Against Antiviral T Cells
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity
Recent advances in CAR-T cell engineering
Nanobody-based CAR-T cells for cancer immunotherapy
Targeting glycosylation of PD-1 to enhance CAR-T cell cytotoxicity
Camel nanobody-based B7-H3 CAR-T cells show high efficacy against large solid tumours
Engineering CAR-T cells
Interleukin-7 expression by CAR-T cells improves CAR-T cell survival and efficacy in chordoma
Nanobody‐mediated complement activation to kill HIV ‐infected cells
T cell senescence and CAR-T cell exhaustion in hematological malignancies
CART cells are prone to Fas- and DR5-mediated cell death
Reprogramming T cell differentiation and exhaustion in CAR-T cell therapy
Progranulin Prevents Regulatory NK Cell Cytotoxicity Against Antiviral T Cells
STAT1 signaling shields T cells from NK cell-mediated cytotoxicity